Enjoy complimentary customisation on priority with our Enterprise License!
The bio-detection market is estimated to grow by USD 16.85 billion, at a CAGR of 15.2% between 2023 and 2028. The market's growth hinges on various factors, notably the rising incidence of infectious diseases and cancer. There's a notable surge in efforts towards rapid disease diagnostics, spurred by the urgency to identify and treat illnesses swiftly. Additionally, the proliferation of alliances among healthcare entities and research institutions plays a pivotal role. These collaborations foster innovation and the development of advanced diagnostic technologies, further propelling market expansion. Furthermore, governmental support and funding initiatives bolster these efforts, creating a conducive environment for market growth. As healthcare priorities shift towards early detection and effective management of diseases, these dynamics underscore the market's trajectory towards continuous advancement and broader accessibility of diagnostic solutions.
To learn more about this report, Download Report Sample
The market is witnessing significant growth due to the increasing awareness and concern over airborne diseases and environmental degradation. Biodetection systems play a crucial role in identifying potential pathogens, including viruses, bacteria, and toxins, to ensure public health and safety. The market is driven by the clinical urgency to diagnose cardiovascular disease, arsenicosis, cancer, and chronic kidney disease at an early stage. Biodefense systems and the threat of bio-terrorism, including incidents such as the Ricin letters and H1N1 attacks, are also major factors fueling market growth. Airborne chemicals and biological weapons pose a significant threat, and governments worldwide are investing in bio-detection technologies and instruments to enhance their bio-surveillance capabilities. The market is expected to continue its growth trajectory, with increasing government support and bio-detection budgets playing a key role. The potential for integration with healthcare systems and advancements in technology are also expected to provide opportunities for market expansion.
The increasing incidence of infectious diseases is notably driving the biodetectors and accessories market growth. The prevalence of infectious diseases such as tuberculosis, human immunodeficiency virus (HIV), pneumonia, and malaria has increased. HIV attacks, for example, eventually destroy the immune system, resulting in Acquired immunodeficiency syndrome (AIDS), although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised. There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes.
For instance, the Aid for AIDS program understands the needs of patients and provides them with the required treatments and tools to lead normal lives. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to boost the growth of the global market significantly during the forecast period.
The increasing applications of microorganisms are an emerging trend in the market. Microorganisms are increasingly being used for producing various products, such as food items and beverages, food additives and supplements, and microbial enzymes. These products are of economic importance. Industrial microbiologists perform various activities for producing commercial products from microorganisms, these activities include the isolation of microorganisms from nature, screening for product formations, maintaining cultures, and retrieving products, followed by their purification. All these activities require bio-detection products such as microbial identification systems, kits, and reagents.
Further, some products manufactured with the help of microorganisms are beverages and amino acids. Microorganisms such as yeasts are used to produce beverages such as beer, wine, whiskey, brandy, and rum. Microorganisms also help produce amino acids such as lysine and glutamic acid, which are used in the food industry as nutritional supplements in bread products. Hence, the increased use of microorganisms in the production of food and beverage products is expected to drive market growth and trends during the forecast period.
The inadequate healthcare services in developing regions is a major challenge impeding market growth. Many people in developing regions do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by the lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as bio-detection.
Countries such as Afghanistan and Bangladesh are grappling with the lack of technology and the appropriate policies to enable the delivery of healthcare services. The stigma or misconception about the gravity of conditions such as sexually transmitted diseases (STDs) further discourages any form of testing, including microbiology testing and the subsequent treatment of infectious diseases. Hence, all of the abovementioned factors will hinder the growth of the global market during the forecast period.
Key Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Bertin Technologies SAS - The company designs and manufactures measurement, observation, detection systems, and instruments for critical applications. The key offerings of the company include bio-detection.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the clinical segment will be significant during the forecast period. The clinical segment was a leading segment in the global market owing to increasing demand from critically ill patients after the pandemic and the increasing geriatric population across the world.
Get a glance at the market contribution of various segments Request a PDF Sample
The clinical segment was valued at USD 4.74 billion in 2018. There are increasing cases of infectious diseases such as influenza and measles in developed and developing countries across the world, which, in turn, increases the demand for bio-detection in clinics. This will be the primary factor that will be responsible for driving the segment growth during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America was the largest revenue contributor to the global market in 2023, with the US being the leading country. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several companies in the country offering a wide range of bio-detection products are aiding the growth of the market.
In addition, the market in North America is led by the US and Canada owing to the increase in focus on drug discovery and development by several pharmaceutical companies, such as Novartis and Pfizer. R&D for drug development and diagnosis of diseases requires bio-detection products. The drug discovery market is expected to grow owing to the emergence of new fatal diseases, the high prevalence of infectious diseases such as respiratory infections and sexually transmitted diseases, and the increased demand for personalized medicines. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of bio-detection in the region, which in turn, will boost the regional market growth during the forecast period.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
You may also interested in below market reports:
The market is witnessing a strong presence due to the increasing awareness of environmental degradation and the potential threat of airborne diseases, bioterrorism, and biological agents. The market is driven by the clinical urgency to identify and respond to infection transmission, especially in the context of cardiovascular disease, arsenicosis, cancer, and chronic kidney disease. Biodetection technology plays a crucial role in biodefense systems, enabling faster reaction to bioterrorism and bioattacks. Harmful organism biorecognition is a key application area, with technologies such as microarrays, microfluidics-based biodetectors, and electrochemiluminescence-based biodetectors gaining popularity.
In addition, these technologies offer multiple agent recognition capabilities and lower detection limits, making them suitable for the detection of minute viruses and hazardous biological weapons. Public awareness campaigns and healthcare organizations are increasingly investing in rapid diagnostic kits and PPE to mitigate the risks of contact illnesses. The market is further propelled by the need for low-level detection capability in various sectors, including the medical field, counter-terrorism, and homeland security. The market is expected to grow significantly in the coming years, driven by the increasing demand for early detection and response to various health threats.
Market Scope |
|
Report Coverage |
Details |
Page number |
178 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 15.2% |
Market Growth 2024-2028 |
USD 16.85 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
12.86 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, China, Germany, Canada, and UK |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
20/20 GeneSystems Inc., 3M Co., Abbott Laboratories, AdVnt Biotechnologies LLC, Agilent Technologies Inc., Alexeter Technologies LLC, Bertin Technologies SAS, Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Illumina Inc., MBio Diagnostics Inc., Physical Sciences Inc., PositiveID Corp., Research International Inc., Response Biomedical Corp., Sense Biodetection Inc, Smiths Group Plc, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market growth analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the market forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.